Abstract:BACKGROUND & AIMS: Visceral smooth muscle cells (SMCs) are an integral component of the gastrointestinal (GI) tract that regulate GI motility. SMC contraction is regulated by post-translational signaling and the state of differentiation. Impaired SMC contraction is associated with significant morbidity and mortality, but the mechanisms regulating SMC-specific contractile gene expression, including the role of long noncoding RNAs (lncRNAs), remain largely unexplored. Herein, we reveal a critical role of Carmn (cardiac mesoderm enhancer-associated noncoding RNA), an SMC-specific lncRNA, in regulating visceral SMC phenotype and contractility of the GI tract. METHODS: Genotype-Tissue Expression and publicly available single-cell RNA sequencing (scRNA-seq) data sets from embryonic, adult human, and mouse GI tissues were interrogated to identify SMC-specific lncRNAs. The functional role of Carmn was investigated using novel green fluorescent protein (GFP) knock-in (KI) reporter/knock-out (KO) mice. Bulk RNA-seq and single nucleus RNA sequencing (snRNA-seq) of colonic muscularis were used to investigate underlying mechanisms. RESULTS: Unbiased in silico analyses and GFP expression patterns in Carmn GFP KI mice revealed that Carmn is highly expressed in GI SMCs in humans and mice. Premature lethality was observed in global Carmn KO and inducible SMC-specific KO mice due to GI pseudo-obstruction and severe distension of the GI tract, with dysmotility in cecum and colon segments. Histology, GI transit, and muscle myography analysis revealed severe dilation, significantly delayed GI transit, and impaired GI contractility in Carmn KO vs control mice. Bulk RNA-seq of GI muscularis revealed that loss of Carmn promotes SMC pheno-typic switching, as evidenced by up-regulation of extracellular matrix genes and down-regulation of SMC contractile genes, including Mylk, a key regulator of SMC contraction. snRNA-seq further revealed SMC Carmn KO not only compromised myogenic motility by reducing contractile gene expression but also impaired neurogenic motility by disrupting cell-cell con-nectivity in the colonic muscularis. These findings may have translational significance, because silencing CARMN in human colonic SMCs significantly attenuated contractile gene expres-sion, including MYLK, and decreased SMC contractility. Lucif-erase reporter assays showed that CARMN enhances the transactivation activity of the master regulator of SMC contractile phenotype, myocardin, thereby maintaining the GI SMC myogenic program. CONCLUSIONS: Our data suggest that Carmn is indispensable for maintaining GI SMC contractile function in mice and that loss of function of CARMN may contribute to human visceral myopathy. To our knowledge this is the first study showing an essential role of lncRNA in the regulation of visceral SMC phenotype.

Multifunctional Protein: Cardiac Ankyrin Repeat Protein

Cardiac Ankyrin Repeat Protein Contributes to Dilated Cardiomyopathy and Heart Failure

Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-β Signaling Pathways.

Cardiac Ankyrin Repeat Protein Attenuates Cardiomyocyte Apoptosis by Upregulation of Bcl-2 Expression.

CARMN is an Evolutionarily Conserved Smooth Muscle Cell-Specific LncRNA That Maintains Contractile Phenotype by Binding Myocardin

The Long Noncoding RNA Cardiac Mesoderm Enhancer- Associated Noncoding RNA (carmn) is a Critical Regulator of Gastrointestinal Smooth Muscle Contractile Function and Motility

Discovery of an evolutionarily conserved smooth muscle cell-specific lncRNA<i>CARMN</i>

Abstract 18698: PCBP1 Regulates Alternative Splicing of Aars2 in Congenital Cardiomyopathy

Discovery of an Evolutionarily Conserved Smooth Muscle Cell-Specific Lncrna CARMN

Abstract 16817: Overexpression of CARP Exaggerates Cardiac Hypertrophy and Heart Failure by Accumulation of Calcineurin and P53 in Pressure-Overloaded Mice

Role of apoptosis repressor with caspase recruitment domain (ARC) in cell death and cardiovascular disease

Research progress of ankyrin repeat domain 1 protein: an updated review

The Curious Role of Sarcomeric Proteins in Control of Diverse Processes in Cardiac Myocytes

Changes of Calcium Handling Protein after Acute Myocardial Infarction in Rats and Effect of Carvedilol

Cypher/ZASP Is a Novel A-kinase Anchoring Protein

CARMA3: A potential therapeutic target in non-cancer diseases

RNA-Binding Profiles of CKAP4 as an RNA-Binding Protein in Myocardial Tissues

Epigenetic Regulation of Cardiomyocyte Maturation by Arginine Methyltransferase CARM1

Cypher/Zasp, A Pka Scaffolding Protein To Regulate The Phosphorylation Of L-Type Calcium Channel

Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities

RNA-Binding Proteins in Cardiomyopathies